Literature DB >> 28266670

Size-dependent inhibition of herpesvirus cellular entry by polyvalent nanoarchitectures.

B Ziem1, W Azab2, M F Gholami3, J P Rabe3, N Osterrieder2, R Haag1.   

Abstract

Carbon-based architectures, especially graphene and its derivatives, have recently attracted much attention in the field of biomedicine and biotechnology for their use as pathogen inhibitors or biosensors. One of the major problems in the development of novel virus inhibitor systems is the adaption of the inhibitor to the size of virus particles. We here report the synthesis and biological testing of carbon-based inhibitors differing in size for evaluating the potential size effect on the inhibition of virus entry and replication. In this context, different sized nanomaterials were functionalized with polygylcerol through a "grafting from" polymerization to form new polyvalent nanoarchitectures which can operate as viral inhibitor systems after post-modification. For this purpose a polysulfation was carried out to mimic the heparan sulfates present on cell surfaces that we reasoned would compete with the binding sites of herpes simplex virus type 1 (HSV-1) and equine herpesvirus type 1 (EHV-1), which both cause major global health issues. Our results clearly demonstrate that the inhibitory efficiency is regulated by the size of the polymeric nanomaterials and the degree of sulfation. The best inhibiting graphene sheets were ∼300 nm in size and had a degree of sulfation of ∼10%. Furthermore, it turned out that the derivatives inhibited virus infection at an early stage during entry but did not affect cell-to-cell spread. Overall, tunable polyvalent nanomaterials are promising and efficient virus entry inhibitors, which can likely be used for a broad spectrum of enveloped viruses.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28266670     DOI: 10.1039/c7nr00611j

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  17 in total

Review 1.  Antiviral performance of graphene-based materials with emphasis on COVID-19: A review.

Authors:  Tahereh Seifi; Ali Reza Kamali
Journal:  Med Drug Discov       Date:  2021-05-25

2.  Are graphene and graphene-derived products capable of preventing COVID-19 infection?

Authors:  Pawan Kumar Raghav; Sujata Mohanty
Journal:  Med Hypotheses       Date:  2020-06-24       Impact factor: 1.538

3.  Adaptive Flexible Sialylated Nanogels as Highly Potent Influenza A Virus Inhibitors.

Authors:  Sumati Bhatia; Malte Hilsch; Jose Luis Cuellar-Camacho; Kai Ludwig; Chuanxiong Nie; Badri Parshad; Matthias Wallert; Stephan Block; Daniel Lauster; Christoph Böttcher; Andreas Herrmann; Rainer Haag
Journal:  Angew Chem Int Ed Engl       Date:  2020-06-30       Impact factor: 15.336

Review 4.  An overview of functional nanoparticles as novel emerging antiviral therapeutic agents.

Authors:  Lu Chen; Jiangong Liang
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2020-04-06       Impact factor: 7.328

5.  Can graphene take part in the fight against COVID-19?

Authors:  V Palmieri; M Papi
Journal:  Nano Today       Date:  2020-05-07       Impact factor: 20.722

Review 6.  Recent advances in carbon nanomaterials for biomedical applications: A review.

Authors:  Parand R Riley; Roger J Narayan
Journal:  Curr Opin Biomed Eng       Date:  2021-01-15

7.  Fight against COVID-19: The case of antiviral surfaces.

Authors:  Kamyar Shirvanimoghaddam; Mohammad Karbalaei Akbari; Ram Yadav; Adil K Al-Tamimi; Minoo Naebe
Journal:  APL Mater       Date:  2021-03-01       Impact factor: 5.096

8.  Potential application of biomass derived graphene for COVID-19 pandemic.

Authors:  N F T Arifin; N Yusof; N A H M Nordin; J Jaafar; A F Ismail; F Aziz; W N W Salleh
Journal:  Mater Today Proc       Date:  2021-02-27

9.  Graphene Nanoplatelet and Graphene Oxide Functionalization of Face Mask Materials Inhibits Infectivity of Trapped SARS-CoV-2.

Authors:  Flavio De Maio; Valentina Palmieri; Gabriele Babini; Alberto Augello; Ivana Palucci; Giordano Perini; Alessandro Salustri; Patricia Spilman; Marco De Spirito; Maurizio Sanguinetti; Giovanni Delogu; Laura Giorgia Rizzi; Giulio Cesareo; Patrick Soon-Shiong; Michela Sali; Massimiliano Papi
Journal:  iScience       Date:  2021-06-25

10.  Multivalent nanomedicines to treat COVID-19: A slow train coming.

Authors:  Tanveer A Tabish; Michael R Hamblin
Journal:  Nano Today       Date:  2020-09-04       Impact factor: 18.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.